“Starting and Building Biotech Companies: From Sepracor to Selecta”
Robert L. Bratzler
Executive Chairman, Selecta Biosciences
Friday, April 2, 2010
3:00 pm, Building 66-110
Massachusetts Institute of Technology
Dr. Bratzler is Executive Chairman of Selecta Biosciences, a Watertown-based biotech company pioneering the development of targeted nanoparticle vaccines for treatment and prevention of diseases. Previously, Dr. Bratzler was President and Chief Executive Officer of Coley Pharmaceutical Group from 1998 to the time of its sale to Pfizer in January 2008. A co-founder of Sepracor Inc., a research-based pharmaceutical company, in 1984, Dr. Bratzler also co-founded and helped build and finance several Sepracor group companies, including ChiRex, a pharmaceutical outsourcing company, where Dr. Bratzler served as President and Chief Executive Officer. A former faculty member in the department of chemical engineering at Princeton University and with industrial experience at Procter and Gamble and Polaroid Corporation, Dr. Bratzler received his B.S. degree from the University of Michigan (1968) and his Ph.D. in chemical engineering from the Massachusetts Institute of Technology (1975). Dr. Bratzler lives in Concord, Massachusetts and is married to Lori (Shingleton) Bratzler.